In September, Replit completed a $250M funding round that gave it a $3B valuation. That round was led by Prysm Capital and ...
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback